| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.096 | 0.04 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.05 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.06 |